Axcelis Technologies (ACLS) shares are soaring 5.13% in Wednesday's trading session, demonstrating resilience in the face of mixed analyst actions. The stock's strong performance comes despite a slight price target reduction from one firm, suggesting investors are focusing on the broader positive sentiment surrounding the company.

B. Riley adjusted its price target for Axcelis to $84 from $85, maintaining a Neutral rating. However, this minor downward revision seems to have been overshadowed by more bullish views from other analysts. Notably, Benchmark Co. reaffirmed its Buy rating on ACLS with a significantly higher price target of $105, indicating strong confidence in the company's potential upside.

The overall analyst consensus remains favorable for Axcelis. According to FactSet, the average rating for the stock is overweight, with a mean price target of $96.80. This positive outlook appears to be driving investor enthusiasm, contributing to the stock's impressive intraday gains. The market's reaction suggests that investors are more focused on the long-term potential of Axcelis rather than short-term adjustments in analyst targets.